Patents by Inventor Michael Abrams

Michael Abrams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075883
    Abstract: A vehicle includes a storage compartment, a belt conveyor located in the storage compartment and having a slat belt supported by a pair of rollers, and a shelf operatively coupled to the slat belt and configured to move between a lower stowed position within the storage compartment and an upper deployed position extending outward from the storage compartment.
    Type: Application
    Filed: September 6, 2022
    Publication date: March 7, 2024
    Applicant: Ford Global Technologies, LLC
    Inventors: Stuart C. Salter, David Brian Glickman, Jeff Robert Seaman, Annette Lynn Huebner, George Abram Thornton, Michael John Harmon
  • Publication number: 20220366281
    Abstract: In various embodiments, a character engine models a character that interacts with users The modeling techniques include evaluating user input data that is associated with a user device to identify a user intent and an assessment domain, selecting a first set of inference algorithms from a plurality of inference algorithms based, at least in part, on the user intent and the assessment domain, and applying the user intent and the assessment domain to the first set of inference algorithms to generate a plurality of inferences.
    Type: Application
    Filed: July 25, 2022
    Publication date: November 17, 2022
    Inventors: Michael ABRAMS, Eric HASELTINE
  • Patent number: 11455549
    Abstract: In one embodiment, a character engine models a character that interacts with users. The character engine receives user input data from a user device, and analyzes the user input data to determine a user intent and an assessment domain. Subsequently, the character engine selects inference algorithm(s) that include machine learning capabilities based on the intent and the assessment domain. The character engine computes a response to the user input data based on the selected inference algorithm(s) and a set of personality characteristics that are associated with the character. Finally, the character engine causes the user device to output the response to the user. In this fashion, the character engine includes sensing functionality, thinking and learning functionality, and expressing functionality.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: September 27, 2022
    Assignee: Disney Enterprises, Inc.
    Inventors: Michael Abrams, Eric Haseltine
  • Patent number: 11423317
    Abstract: In one embodiment, a character engine models a character that interacts with users. The character engine receives user input data from a user device, and analyzes the user input data to determine a user intent and an assessment domain. Subsequently, the character engine selects inference algorithm(s) that include machine learning capabilities based on the intent and the assessment domain. The character engine computes a response to the user input data based on the selected inference algorithm(s) and a set of personality characteristics that are associated with the character. Finally, the character engine causes the user device to output the response to the user. In this fashion, the character engine includes sensing functionality, thinking and learning functionality, and expressing functionality.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: August 23, 2022
    Assignee: Disney Enterprises, Inc.
    Inventors: Michael Abrams, Eric Haseltine
  • Patent number: 11311598
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: April 26, 2022
    Assignee: Soligenix, Inc.
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John North, Michael Abrams
  • Publication number: 20200323946
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 15, 2020
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John Carpenter, Michael Abrams
  • Patent number: 10253068
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: April 9, 2019
    Assignee: Soligenix, Inc.
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John North, Michael Abrams
  • Publication number: 20180170964
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 21, 2018
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John North, Michael Abrams
  • Publication number: 20180165596
    Abstract: In one embodiment, a character engine models a character that interacts with users. The character engine receives user input data from a user device, and analyzes the user input data to determine a user intent and an assessment domain. Subsequently, the character engine selects inference algorithm(s) that include machine learning capabilities based on the intent and the assessment domain. The character engine computes a response to the user input data based on the selected inference algorithm(s) and a set of personality characteristics that are associated with the character. Finally, the character engine causes the user device to output the response to the user. In this fashion, the character engine includes sensing functionality, thinking and learning functionality, and expressing functionality.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 14, 2018
    Inventors: Michael ABRAMS, Eric HASELTINE
  • Patent number: 9850279
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: December 26, 2017
    Assignee: Soligenix, Inc.
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John North, Michael Abrams
  • Publication number: 20170175523
    Abstract: A method for analyzing total oil in place and fraction that is movable oil in a fine gain rock formation includes monitoring thermal extraction of hydrocarbon and non-hydrocarbon compounds from a sample of a subsurface formation by heating the sample. The heating has a selected initial temperature, and a temperature increase at a selected rate to a final temperature. The extracted hydrocarbon and non-hydrocarbon compounds are passed through a capillary column to a flame ionization detector. Types of hydrocarbon and non-hydrocarbon compounds and relative fractional amounts of each type thereof are determined from the sample by analyzing a chemical thermogram generated by the flame ionization detector.
    Type: Application
    Filed: March 30, 2015
    Publication date: June 22, 2017
    Applicant: APACHE CORPORATION
    Inventor: Michael A. Abrams
  • Publication number: 20170049474
    Abstract: A trocar or surgical port assembly includes an annular body attachable to a patient at an incision in a patient. The annular body includes a cylindrical insert portion defining a proximal end and a distal end and a flange disposed at the proximal end of the cylindrical insert portion. A skirt is attached to the distal end of the cylindrical insert portion and extends distally from the annular body and includes a flexible web and a wire attached to the flexible web that in a multiple looped configuration of non-intersecting curved portions positioned in the vicinity of the distal portion of the skirt to enable the flexible web to be biased via a biasing force exerted by the wire into a funnel-shaped open configuration having an opening of the skirt at the distal portion of the skirt that is larger than an opening of the skirt at the proximal portion.
    Type: Application
    Filed: September 23, 2016
    Publication date: February 23, 2017
    Inventors: Gregory Piskun, Oleg Shikhman, Christopher Battles, Patrick N. Gutelius, Mark J. DeBisschop, Jeffrey H. MacDonald, Frank Rende, Michael Abrams, Anatoly Konik, Dan Rottenberg
  • Patent number: 9492195
    Abstract: A surgical port comprising a body and first and second cannula extending from the body and movable with respect to the body via an instrument inserted through the respective cannula. The cannulas can extend distally from the body and can include one or more seals. A port assembly and first and second instruments manipulatable in a crossed configuration are also disclosed.
    Type: Grant
    Filed: January 19, 2015
    Date of Patent: November 15, 2016
    Assignee: Covidien LP
    Inventors: Gregory Piskun, Oleg Shikhman, Christopher Battles, Patrick N. Gutelius, Mark J. DeBisschop, Jeffrey H. MacDonald, Frank Rende, Michael Abrams, Anatoly Konik, Dan Rottenberg
  • Publication number: 20160229890
    Abstract: Preclinical data obtained in models of chemotherapy-induced mucositis, radiation-induced mucositis, neutropenic infection and colitis indicate oral mucositis is a promising indication for Innate Defense Regulator (IDR) peptides. Preclinical efficacy results obtained with IDRs in mouse and hamster models of mucositis indicate that dosing every third day should be able to cover the mucositis “window” with seven to fourteen doses, depending on the duration of chemotherapy or radiation exposure. IDRs have also shown efficacy in mouse models of chemotherapy-induced oral and gastrointestinal mucositis, consistent with the response of the innate immune response to chemotherapy and/or radiation damage. IDRs are also effective at reducing bacterial burden and improve survival in the presence or absence of antibiotic treatment in various murine infection models.
    Type: Application
    Filed: August 11, 2014
    Publication date: August 11, 2016
    Inventors: Oreola Donini, Annett Rozek, Jackson Lee, John North, Michael Abrams
  • Patent number: 9314267
    Abstract: Various embodiments of a laparoscopic trocar assembly are disclosed. The port assemblies include inserted parts that protect the patient's tissues at the point of deployment. The port assemblies include seals for maintaining pneumoperitoneum both when instrument are being used and when instruments are not inserted.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: April 19, 2016
    Assignee: Covidien LP
    Inventors: Gregory Piskun, Christopher Battles, Frank Rende, Michael Abrams, Oleg Shikhman
  • Publication number: 20150148613
    Abstract: A surgical port comprising a body and first and second cannula extending from the body and movable with respect to the body via an instrument inserted through the respective cannula. The cannulas can extend distally from the body and can include one or more seals. A port assembly and first and second instruments manipulatable in a crossed configuration are also disclosed.
    Type: Application
    Filed: January 19, 2015
    Publication date: May 28, 2015
    Inventors: Gregory Piskun, Oleg Shikhman, Christopher Battles, Patrick N. Gutelius, Mark J. DeBisschop, Jeffrey H. MacDonald, Frank Rende, Michael Abrams, Anatoly Konik, Dan Rottenberg
  • Publication number: 20150080931
    Abstract: Various embodiments of a laparoscopic trocar assembly are disclosed. The port assemblies include inserted parts that protect the patient's tissues at the point of deployment. The port assemblies include seals for maintaining pneumoperitoneum both when instrument are being used and when instruments are not inserted.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Gregory Piskun, Christopher Battles, Frank Rende, Michael Abrams, Oleg Shikhman
  • Patent number: 8961407
    Abstract: A surgical port comprising a body and first and second cannula extending from the body and movable with respect to the body via an instrument inserted through the respective cannula. The cannulas can extend distally from the body and can include one or more seals. A port assembly and first and second instruments manipulatable in a crossed configuration are also disclosed.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: February 24, 2015
    Assignee: Covidien LP
    Inventors: Gregory Piskun, Oleg Shikhman, Christopher Battles, Patrick N. Gutelius, Mark J. DeBisschop, Jeffrey H. MacDonald, Frank Rende, Michael Abrams, Anatoly Konik, Dan Rottenberg
  • Patent number: 8911365
    Abstract: Various embodiments of a laparoscopic trocar assembly are disclosed. The port assemblies include inserted parts that protect the patient's tissues at the point of deployment. The port assemblies include seals for maintaining pneumoperitoneum both when instrument are being used and when instruments are not inserted.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: December 16, 2014
    Assignee: Covidien LP
    Inventors: Gregory Piskun, Christopher Battles, Frank Rende, Michael Abrams, Oleg Shikhman
  • Patent number: 8888695
    Abstract: Various embodiments of a laparoscopic trocar assembly are disclosed. The port assemblies include inserted parts that protect the patient's tissues at the point of deployment. The port assemblies include seals for maintaining pneumoperitoneum both when instrument are being used and when instruments are not inserted.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: November 18, 2014
    Assignee: Covidien LP
    Inventors: Gregory Piskun, Christopher Battles, Frank Rende, Michael Abrams, Oleg Shikman